The CAS SciFinder Discovery Platform expansion unlocks human-indexed insights from journals and patents in over 50 languages dating back to 1957 and 70 million biosequences curated by CAS scientists
The FDA grants ODD status to medicines and potential new medicines intended for the treatment, diagnosis or prevention of rare diseases or disorders that affect fewer than 200,000 people in the US
UCB plans to submit regulatory applications in Q3 2022
First of its kind integrated Heart Health Programme on its Health Station ‘hPod’
The hospital will be operated under the name and style of Max Super Speciality Hospital, Dwarka
First Positive Study for KEYTRUDA in Adjuvant Stage IB-IIIA NSCLC
SAGE recommends additional third dose of the vaccine administered to immunocompromised persons
Patient with acute Covid-19 infection treated at BGS Gleneagles Global Hospital
The data has been shared with the U.S.FDA as part of an ongoing rolling submission for Emergency Use Authorisation
Organised by the Indian Stroke Association, it has attracted over 800 doctors from India and overseas
Subscribe To Our Newsletter & Stay Updated
